Treatments to remove precancerous cervical lesions don't seem to affect a woman's ability to become pregnant, new research found.
The use of diagnostic colposcopy and biopsy and other procedures to diagnose and treat precancerous cervical lesions does not appear to decrease a woman’s chances of becoming pregnant.
In a Kaiser Permanente Northwest study published in PLOS ONE, researchers looked at medical records of nearly 100,000 women over a 12-year span. They found that women who underwent the common surgical procedures used for diagnosing and treating precancerous cervical lesions were actually more likely to become pregnant.
- Procedures and treatments used to address precancerous cervical lesions do not appear to decrease a woman’s chances of becoming pregnant.
- This is reassuring news for the millions of women who have had one of these procedures and want to grow their family.
“While the data we collected did not include sexual history, it is possible that the women who had these procedures may have been more sexually active than the untreated group, and that would explain the higher pregnancy rates,” said Allison Naleway, PhD, lead author and senior investigator at the Kaiser Permanente Center for Health Research in Portland, Oregon, in a news release.
Still, Naleway said the study helps to alleviate a fear that the surgical procedures weaken the cervix and reduce fertility. The study included both excisional procedures (LEEP, LLETZ, or conization) and ablative procedures (electro or thermal) that remove the abnormal cells to prevent their progression to cervical cancer. These procedures have been linked to an increase in risk of preterm delivery, but research to better understand this link is limited, the study authors explain.
Of the women who had cervical treatment, 14% got pregnant, compared with 9% of women who did not have a procedure and 11% of women who had a biopsy or colposcopy. After adjusting for age, contraceptive use, and infertility, women who had a treatment procedure were almost 1.5 times more likely to conceive compared with women who were untreated.
In reaching that conclusion, the researchers found 570 pregnancies following cervical treatment in 4137 women, 1533 pregnancies following a diagnostic procedure in 13,767 women, and 7436 pregnancies in a frequency-matched sample of 81,435 women unexposed to treatment or diagnostic procedures.
Next, the researchers are looking at whether these procedures affected birth outcomes, such as preterm delivery. Results of that study are expected later this year.
Balancing VTE and bleeding risks in gynecologic cancer surgeries
December 6th 2024A comprehensive analysis shows the benefits of thromboprophylaxis often outweigh the bleeding risks during gynecologic cancer procedures, though patient-specific risk factors are crucial for decision-making.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More